US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Lexaria Bioscience Corporation (LEXXW)
Lexaria Bioscience Corporation (LEXXW) ニュース

LEXXW

Lexaria Bioscience (LEXXW)

Lexaria Bioscience Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:LEXXW

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/12	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2024/06/12	06 : 00	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2024/06/04	02 : 05	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2024/05/16	06 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2024/05/11	06 : 24	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2024/05/11	06 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2024/05/11	06 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2024/05/11	05 : 34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/07/22	21 : 18	InvestorsHub NewsWire	Lexaria Summarizes Successful Antiviral Drug Studies and Ongoing Strategy	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/07/21	20 : 27	InvestorsHub NewsWire	Lexaria's DehydraTECH Significantly Enhances Delivery of Colchicine in Study VIRAL-A20-3	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/07/15	21 : 14	InvestorsHub NewsWire	Lexaria Completes Successful Antiviral Drug Molecular Characterization Study With Canada's National Research Council	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/06/03	21 : 05	InvestorsHub NewsWire	Lexaria's DehydraTECH(TM)-Enabled Remdesivir and Ebastine Effectively Inhibit the COVID-19 SARS-CoV-2 Virus	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/05/20	20 : 16	InvestorsHub NewsWire	Lexaria's Newest DehydraTECHTM 2.0 Formulation Tested in Study HYPER-A21-2 Demonstrates Its Strongest CBD Absorption..cont	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/05/12	20 : 18	InvestorsHub NewsWire	Lexaria Strengthens its International Patent Portfolio to 19 Patents Granted	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/05/06	20 : 35	InvestorsHub NewsWire	Lexaria Issues Successful Results from First 2021 Study, HYPER-A21-1	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/04/14	20 : 37	InvestorsHub NewsWire	Lexaria's DehydraTECHTM Technology Utilized in Amari's "Everyday Calm," Named a Top CBD Product Pick by New Hope Network	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/04/06	20 : 16	InvestorsHub NewsWire	Lexaria to Evaluate DehydraTECHTM in Multiple New Markets	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/03/24	21 : 00	InvestorsHub NewsWire	Lexaria Technology Generates Positive Stability Testing for World-Class Ready to Drink CBD Beverages	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/03/16	20 : 39	InvestorsHub NewsWire	Lexaria's Antiviral Drug Evaluation Program Progressing	NASDAQ:LEXXW	Lexaria Bioscience Corporation
2021/03/15	21 : 30	InvestorsHub NewsWire	Rapid Progress in Hypertension Studies by Lexaria	NASDAQ:LEXXW	Lexaria Bioscience Corporation

Showing the most relevant articles for your search:NASDAQ:LEXXW

1

Verizon Communications

US Dollar vs Euro

US Dollar vs Sterling

Bank of America

US Dollar vs Yen

Gold vs US Dollar

Energy Select Sector SPDR

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約